Skip to main content
See every side of every news story
Published • loading... • Updated

Bristol Myers raises 2026 revenue forecast, lowers EPS due to charge

The drugmaker cited strong sales of newer medicines and now expects 2026 revenue of $49.75 billion to $50.25 billion.

Summary by WTVB
By Deena Beasley Oct 29 (Reuters) - Bristol Myers Squibb raised its full-year revenue forecast on Thursday, citing strong sales of its newer medicines, but lowered its 2026 earnings per share projection due to ​a hefty acquisition-related charge. The U...

6 Articles

ReutersReuters
+2 Reposted by 2 other sources
Center

Bristol Myers raises 2026 revenue forecast, lowers EPS due to charge

·London, United Kingdom
Read Full Article

(Teleborsa) - Bristol Myers Squibb, an American biopharmaceutical giant, closed the third quarter of 2026 with revenues of 13.1 billion dollars, up 7% compared to 12.2 billion dollars...

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources are Center, 50% of the sources lean Right
50% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

WTVB broke the news on Thursday, October 29, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal